Wordt geladen...
Inhibition of esophageal cancer growth through the suppression of PI3K/AKT/mTOR signaling pathway
BACKGROUND: The phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway is implicated in several cancers. AKT allosteric inhibitor MK2206 and dual PI3K and mTOR inhibitor BEZ235 are promising drug candidates with potential anti-tumor effects. PURPOSE...
Bewaard in:
| Gepubliceerd in: | Onco Targets Ther |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6756275/ https://ncbi.nlm.nih.gov/pubmed/31571914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S205457 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|